Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer

BACKGROUND: Two first-line (1L) bevacizumab trials showed the prognostic value of primary tumour location in metastatic colorectal cancer (mCRC). In this retrospective subgroup analysis, further analysis of the predictive effect of bevacizumab is presented. METHODS: Patients with sidedness informati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Loupakis, Fotios, Hurwitz, Herbert I., Saltz, Leonard, Arnold, Dirk, Grothey, Axel, Nguyen, Quynh Lan, Osborne, Stuart, Talbot, Jonathan, Srock, Stefanie, Lenz, Heinz-Josef
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6288128/
https://ncbi.nlm.nih.gov/pubmed/30487637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0304-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados